The family of a Wisconsin man is suing after they say he died from an asthma attack when his medication price rose from $66 ...

The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and ...

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

Specifically, Dupixent is approved to treat moderate to severe asthma that is either: dependent on treatment with an oral corticosteroid, or eosinophilic (caused by an increase in eosinophils ...

Systemic corticosteroids (CS) should be considered as first-line treatment for acute asthma exacerbations, especially severe exacerbations. They may sometimes require a few hours or more to ...

Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

Arterial-Blood Studies during Treatment of Severe Refractory Bronchial Asthma in Case 2 on May 17, after Theophylline and Epinephrine (1), at 8:00 A.M., when the Asthma Was Refractory to ...

has a place in the effort to avert acute attacks; however, its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...